학술논문
Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial
Document Type
Article
Author
Source
In: The Lancet HIV . (The Lancet HIV, December 2018, 5(12):e715-e722)
Subject
Language
English
ISSN
23523018